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Introduction
The medical progress in the field of reproduction has
only been possible because of parallel scientific dis-
coveries. Development in genetics, medical imagery,
hormonology, and animal reproduction applied to
reproductive medicine allowed this progress. In addi-
tion, this is a new trend in our modern society which
encourages infertile couples to obtain children. In this
domain, reproductive medicine has been particularly
efficient.
Ineluctable is no more. Everything should be possi-
ble or almost. The wish to have children is now realis-
able for couple who were until now with no hope. Bet-
ter understanding of ovulation, spermatogenesis, news
drugs (gonadotrophins, GnRH analogue: agonist or
antagonist, prolactin inhibitor) contribute to ameliorate
ovulation induction, and so IVF procedures. The first
researches about animal reproduction started almost
one century. But, we had to wait until the biologist
Robert Edwards, after thirteen years of persistence and
intractability, to obtain the birth of Louise Brown. This
event introduced in the all world news therapeutic pos-
sibilities in infertility treatment.  
In 1990, for the first time a spermatozoa has been
deposed under the zona pellucida, followed later by
the first intracytoplamsic sperm injection opened the
treatment to the male infertility. Next step was preim-
plantation genetic diagnosis (PGD), allowing to select
an embryo without any genetic disease.  
Last progress has been in vitro maturation (IVM)
consisting to collect oocytes without ovarian hyper-
stimulation, and to make them finish their maturation
in culture. This restores hope for patient with a poly-
cystic ovary syndrome.
We are only at the beginning of new discoveries
about human embryo development and its anomaly. 
New trends in our modern societies: ethical
questions and legal aspects
We have observed a trend to a new morality with the
changes of our modern society. From this trend
appeared new request like lesbian couples, transsexu-
al, singleton parent, surrogates mother, or asks from
widows. But all these new trends are not compatible
with the ART laws that govern the normality of the
manners. In front of these situations, the physician has
no standard solution to propose, he normally has to
follow the laws form his country. But he can, using his
ethic sensitivity with the help of ethic committees
(Epelboin et al. 2005), choose the most adapted solu-
tion directing these patients to different countries with
different laws, even if his morality sensitivity is
against it. This is an obligation and it brings the ques-
tion to the accessibility to the best treatment for
patients. For example, in Italy, no gamete donation or
embryo cryopreservation is allowed, or in Germany
and Norway, oocyte donation are forbidden. So what
can they propose to the patients with premature ovari-
an failure or genetic diseases. If the best care for our
patients isn't in our country we have to send our
patients to others countries. This is why new legisla-
tion concerning the cross-border reproductive care has
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been recently discussed (Pennings et al. 2008). This
new law 15 has for objective to reduce or limit the
number of patients that have to travel abroad and to
guarantee the safety and quality of the treatment wher-
ever it is provided. Indeed in some countries very few
laws govern the IVF reproduction which bring to dif-
ferent excesses. To fight against these practices a sys-
tem of certification has to be developed. This form of
civil disobedience which intends to change the exist-
ing legislation has the advantage to engage this discus-
sion for new legislation. Now, there will be at least 
a partial reimbursement for treatment to ensure equi-
table access for all citizens, extending the probability
of health insurance (ESHRE et al. law 14 2008). 
The new trend of our modern society meet a hudge
resistance with the ART legislation but also with reli-
gion. Sexuality and reproduction left the divine aspect
to be transferred to human responsability. After work-
ing, feeding, even sexuality lost its religious traint
which was present since antiquity with different gods
or godesses. But this is not so simple for these reli-
gions, which solutions to reproductive problems are
becoming obsolete and possibly dangerous (Mori et al.
2008). The pressure of the Vatican on Catholic univer-
sities in Belgium and in Italy to abandon IVF is mount-
ing and is disastrous for research (Brosers et al. 2007).
Religion and reproductive medicine must be separated
and not interfer with the care of our patients.   
The new advances in genetic research have opened
the pandora's box: new possibilities of preimplantation
diagnosis offer new possibilities of drifts. Indeed
american physician has just proposed for couple to cre-
ate a perfect child choosing, the sex, the color of his
eyes, hair with preimplantation diagnosis. Indeed,
preimplantation diagnosis in the United States of
America are not controlled by federal laws at the dif-
ferences of France. In France, therapeutic possibilities
of preimplantation diagnosis are strictly controlled by
the bioethic legislation. It can only be used to prevent
the transmission of genetic diseases with a particular
gravity or to try to obtain a cure for a precedent child
with the diagnosis of HLA compatibility. This particu-
lar point is essential for the good pratice (Himmel 
et al. 2007, Noble et al. 2008). 
Next challenges
Contrary to popular belief, infertility in resource-poor
countries is a major health problem. While infertility
concern between 8 and 12% of the couples, this rate go
up to 30% in Sub-Saharan Africa (Pennings et al.
2009). For this reason, women may be disinherited,
ostracized as they are perceived as a source of evil,
subjected to physical and psychological violence and
even killed. In these different countries, only richest
people can have access to reproductive medicine
because of the absence of any medical insurance. This
inequity of basic products and health care cannot be
accepted. The majority of reproductive care are con-
centrated in developed countries (ESHRE law 14
Human Reprod 2008). The use of public funds cannot
be justified unless the costs of infertility treatment can
be reduced considerably. First, infertility is directly
correlated to the health policy of these differents coun-
tries. In India, the introduction of "the National Fami-
ly Health Survey" in 2000 has brought the rate of infer-
tility to 3.5% of married women against 9 to 35% for
African countries. In fact, the first cause of infertility
in developing countries is tubal infertility secondary to
infections: 35 to 65% in Nigeria (Otolorin et al. 1987,
Otubu et al. 1990) and 77% in South Africa (Chigu-
madzi et al. 1998). This pathology is directly related to
the absence of any politic health care. For this reason
reproductive care can't be considered without a global
health policy including the education and prevention
of sexual diseases like HIV or salpingitis, but also an
access to contraception and family planning. So, this
must include a better formation of the medical and
paramedical corps. At this condition, infertility treat-
ment can be compatible with the problem of overpop-
ulation in these countries (Ombelet et al. 2007, 2008,
Dickens et al. 2007, Prennings et al. 2009). The use of
mild stimulation should allow a prevention of the risk
of high rate pregnancies or hyperstimulation syndrome
that should become a real medical risk in these coun-
tries. The other advantage of mild stimulation is the
reduction of the economical weight.   
The next challenge which has already began is the
fertility conservation for the young patients suffering of
a cancer. For this, new tools are actuallys studied like
oocyte vitrification, oocyte and embryo cryopreserva-
tion, and the ovarian transplantation. There are already
several success with livebirths after ovarian autotrans-
plantation (Donnez et al. 2004, Andersen et al. 2008,
Schmidt et al. 2005, Demeestere et al. 2006) or vitrifi-
cation efficiency (Yoon et al. 2007, Kim et al. 2009). 
What's next?
Reproductive medicine has for first objective to treat
infertile people, but the science advancies has opened
new possibilities like the cloning or the research on the
stem cells. On this different points, the law has clearly
decided with the interdiction of the human cloning, the
study on stem cell has first been prohibited with the
bioethics laws of 1994, but has been finally autorised
in 2006 for the research with a special dispensation for
a maximum of five years. One of the objectives is the
control of cell differentiation from stem cell.
How can a stem cell be transformed in a muscular
cell, a neurone or a blood cell? This knowledge should
be the first step to a medical revolution: the cellular
therapy (this should allow us to replace pathological
cells by healthy ones directly in the organ).
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Scientific cloning, consisting to remove a cell core
from an adult cell to an embryo cell for therapeutic use
remains a future medical challenge. But this must
inevitably pass by a precise understanding of genetics
mechanisms allowing to obtain an embryo develop-
ment from an adult cell core. Mechanisms of anarchic
proliferation of tumoral cells may help in this under-
standing as it is a similar process for the cloning cells.
But additional knowledge about cells programming
and development are at this point necessary.   
Conclusion 
Our modern society is changing quickly, so we, physi-
cians, religious, and politics have to adjust our care for
our patients. In France the bioethics laws are regularly
revised to try to answer to this mutation. This adapta-
tion is necessary no to become obsolete. The next chal-
lenges are huge in particularly the development of
health and ART policy in developing countries. Like
the society, our reproductive medicine will know too a
mutation in the next years with in particular the possi-
bilities offered by the stem cells. But all this knowl-
edge has to be controlled by the moral, the ethics and
the laws to avoid any drift.
Very few medical specialities have such a large a
wealth and interferences between its medical practice
and ethical or philosophical questions. These questions
had to be posed because of the evolution of our mod-
ern society.
Do we have to accept lonely women, homosexual
couples nor post-menopausal patients? What about the
choice of the children's sexe? Nor the surrogate moth-
ers? Or artificial uterus? Is it reasonable to produce
artificially spermatozoa nor oocyte?
Do we have to accept anything in the name of med-
ical progress? Where does the patients freedom stop?
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